A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 970-973

  Nelson, Steve ^a   Heyder, Albrecht M ^b   Stone, Judy ^c   Bergeron, Michel G ^d   Daugherty, Steven ^e   Peterson, Gregory ^f   Fotheringham, Nick ^g   Welch, William ^g   Milwee, Steven ^g   Root, Richard ^h  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Atlantic Pulmonary Associates   (United States)

^c Memorial Hospital   (United States)

^d LAVAL UNIVERSITY   (Canada)

^e USA   (United States)

^f Mercy Hospital Medical Center   (United States)

^g AMGEN INC   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; AUSTRALIA; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART FAILURE; HUMAN; LEUKOCYTE COUNT; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPTIC SHOCK; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; DOUBLE-BLIND METHOD; FEMALE; FILGRASTIM; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0033823702     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315775     Document Type: Article

References (11)

1. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia: CAP Study Group
2. Time to resolution of morbidity: An end point for assessing the clinical cure of community-acquired pneumonia
3. Community acquired pneumonia requiring hospitalization: 5-year prospective study
4. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
5. Levels of serum granulocyte colony-stimulating factor in patients with infections
6. Granulocyte colony-stimulating factor: Role and relationships in infectious diseases
7. The use of granulocyte colony-stimulating factor after liver transplantation
8. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor
9. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection
10. Severe community-acquired pneumonia: Epidemiology and prognostic factors
11. Severe community-acquired pneumonia: Etiology, prognosis, and treatment